Catalyst Wire Dossier Catalyst Wire Dossier

Irbesartan/Hydrochlorothiazide

irbesartan/hydrochlorothiazide · Sanofi
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Irbesartan/Hydrochlorothiazide, covering 2007-12-07 to 2011-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension [Phase 3]

See pricing